We are live on ! Find out more
SBRA icon

Sabra Healthcare REIT

332 hedge funds and large institutions have $2.96B invested in Sabra Healthcare REIT in 2017 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 121 increasing their positions, 122 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

0.92% more ownership

Funds ownership: 87.63%88.55% (+0.92%)

1% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 122

6% less first-time investments, than exits

New positions opened: 47 | Existing positions closed: 50

1% less funds holding

Funds holding: 337332 (-5)

12% less capital invested

Capital invested by funds: $3.37B → $2.96B (-$413M)

19% less call options, than puts

Call options by funds: $3.55M | Put options by funds: $4.4M

Holders
332
Holders Change
-5
Holders Change %
-1.48%
% of All Funds
7.53%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
47
Increased
121
Reduced
122
Closed
50
Calls
$3.55M
Puts
$4.4M
Net Calls
-$851K
Net Calls Change
+$3.52M
Name Holding Trade Value Shares
Change
Change in
Stake
BTIS
326
BB&T Investment Services
North Carolina
$1K +$1.07K +54 New
WA
327
Waverly Advisors
Alabama
$1K +$1.21K +61 New
SWA
328
Sutton Wealth Advisors
Florida
$188
ECM
329
Estabrook Capital Management
New York
$19
ED
330
Exane Derivatives
France
$19
PCG
331
Private Capital Group
Connecticut
$2 +$378 +19 New
Hudson Bay Capital Management
332
Hudson Bay Capital Management
Connecticut
-$18.7M -854,358 Closed
MCM
333
Matarin Capital Management
New York
-$9.24M -421,005 Closed
NFA
334
Nationwide Fund Advisors
Ohio
-$8.69M -395,880 Closed
MWNA
335
Marshall Wace North America
New York
-$8.47M -384,998 Closed
HCM
336
Highbridge Capital Management
New York
-$8.11M -369,634 Closed
KIM
337
Kestrel Investment Management
California
-$7.3M -332,541 Closed
Credit Agricole
338
Credit Agricole
France
-$3.73M -170,142 Closed
Tudor Investment Corp
339
Tudor Investment Corp
Connecticut
-$3.05M -138,995 Closed
PP
340
Paloma Partners
Connecticut
-$2.98M -135,941 Closed
AMI
341
Amica Mutual Insurance
Rhode Island
-$2.65M -120,981 Closed
APFBOT
342
Amica Pension Fund Board of Trustees
Rhode Island
-$2.26M -103,044 Closed
ICOA
343
Investment Centers of America
North Dakota
-$2.12M -96,790 Closed
Two Sigma Advisers
344
Two Sigma Advisers
New York
-$2.06M -93,687 Closed
QSS
345
Quantitative Systematic Strategies
Florida
-$2.05M -93,456 Closed
SCM
346
Stevens Capital Management
Pennsylvania
-$1.92M -87,308 Closed
CCMH
347
Cornerstone Capital Management Holdings
New York
-$1.71M -77,727 Closed
SCM
348
Sterling Capital Management
North Carolina
-$1.34M -60,976 Closed
LOAMU
349
Lombard Odier Asset Management (USA)
New York
-$1.1M -50,193 Closed
OAM
350
Oxford Asset Management
United Kingdom
-$1.04M -48,256 Closed

SBRA Hedge Fund Activity: Q4 2017 in Review

332 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q4 2017, worth a combined $2.96B — down 12% from $3.37B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of SBRA and 47 opened new positions — a net loss of 3 holders — while 122 trimmed existing stakes and 121 added.

The largest buyer was Cohen & Steers, opening a new position worth an estimated $74.1M. The largest seller was Bank of New York Mellon, cutting an estimated $41M.

  • 332 institutional investors held Sabra Healthcare REIT (SBRA) as of Q4 2017, down from 337 in Q3 2017.
  • Funds reported $2.96B of Sabra Healthcare REIT stock for Q4 2017, down 12% quarter-over-quarter.
  • 47 funds opened new Sabra Healthcare REIT positions in Q4 2017 and 50 closed out, a net change of -3 holders.
  • The largest Sabra Healthcare REIT buyer in Q4 2017 was Cohen & Steers, an estimated $74.1M added.
  • The largest Sabra Healthcare REIT seller in Q4 2017 was Bank of New York Mellon, an estimated $41M sold.

Based on aggregated 13F filings for Q4 2017.